CClinicalTrials.gg
RecruitingNCT05749809Updated Sep 13, 2023

The Relationship Between Lower Extremity Selective Motor Control and Gait in Children With Cerebral Palsy

An observational study in Cerebral Palsy, sponsored by Tokat Gaziosmanpasa University. Recruiting at 1 site in Turkey. Open to participants aged 5 Years to 20 Years. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Tokat Gaziosmanpasa University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 6 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
32
Ages
5 Years to 20 Years
Sex
All
01

Study summary

The aim of this study is to examine the relationship between lower extremity selectivity and gait in children with cerebral palsy. 32 volunteer children with CP between the ages of 5-20 will participate in the study. The Selective Control Assessment of the Lower Extremity (SCALE) questionnaire will be used to assess lower extremity selectivity, and the Edinburgh observational gait scale will be used to assess gait. Both assessments are observational.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's planned enrollment of 32 is below the median of 63 across 455 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Tokat Gaziosmanpasa University is the lead sponsor of 164 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 20 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Cerebral palsy

Inclusion criteria

  • Between the ages of 5-20
  • Diagnosed with CP

Exclusion criteria

Exclusion Criteria:

  • Medical complications that limit participation in assessments (for example, severe visual impairment)
  • Lower extremity surgery or botox surgery in the last 6 months
  • Mental problems that cannot understand the commands given
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
32 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Edinburgh Visual Gait Score

    It consists of 17 items scored separately for the right and left lower extremities. Assessments include 6 anatomical levels: trunk, pelvis, hip, knee, ankle, and foot. These anatomical levels are evaluated in the sagittal, coronal and transverse planes. A 3-point ordinal scale is used for scoring. In scoring, a value of 0 indicates normal, a value of 1 indicates moderate deviation from normal, and a value of 2 indicates significant deviation from normal. The scores obtained by watching the camera recordings for each lower extremity are summed and a single score is obtained.

    Time frame: Baseline

  2. Selective Control Assessment of the Lower Extremity (SCALE)

    Evaluates the selective motor control of the lower extremities. It evaluates hip, knee, ankle, subtalar and finger joints bilaterally. Voluntary flexion and extension movements are observed to assess selective voluntary motor control at each joint. Except for the hip joint, which is tested in the side-lying position to allow adequate joint movement, the evaluation of other joints is made in the sitting position.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Faculty of Health Sciences, Tokat Gaziosmanpaşa University
    Tokat, 60250, Turkey
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05749809
Lead sponsor
Tokat Gaziosmanpasa University
Responsible party
Erkan Erol (Assistant Professor, Tokat Gaziosmanpasa University) — Principal investigator
First posted
Mar 1, 2023
Start date
Mar 30, 2023
Primary completion
Jun 30, 2024 (estimated)
Completion
Jul 30, 2024 (estimated)
Last update
Sep 13, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion